Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

Posted on by

The Lancet
Feb 05, 2022 Volume 399 Number 10324 p495-604, e3-e5
https://www.thelancet.com/journals/lancet/issue/current

 

Articles
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
Sue Ann Costa Clemens,et al and the RHH-001 study team
Open Access